Feeds

Drug trial guinea pig faces new medical battle

Diagnosed with cancer

Beginner's guide to SSL certificates

One of the victims of the disastrous drug trial at Northwick Park Hospital earlier this year says he has now been diagnosed with the early stages of cancer.

The disease is attacking New Zealander David Oakley's lymphatic system, part of the immune system. He told The BBC: "It's an early sign of cancer. The best I could actually get was that if we catch it early enough it is treatable."

Six men who were hospitalised by TGN1412, an experimental treatment designed to combat immune conditions such as arthritis and multiple sclerosis, along with certain forms of leukaemia.

But instead of damping down the immune system, the compound over-stimulated it, causing the massive swelling which prompted one woman to describe her boyfriend as looking like "The Elephant Man".

After the tests went badly wrong, the men were warned they could face developing cancer, though there is no proof the trial caused Mr Oakley's condition.

An inquiry by the Medicines and Healthcare products Regulatory Authority found the trial operator Parexel had not liased properly with the drug's German developers TeGenero.

The volunteers' lawyers are currently seeking greater compensation than the initial £5,000 they were offered in April. ®

Choosing a cloud hosting partner with confidence

More from The Register

next story
Renewable energy 'simply WON'T WORK': Top Google engineers
Windmills, solar, tidal - all a 'false hope', say Stanford PhDs
SEX BEAST SEALS may be egging each other on to ATTACK PENGUINS
Boffin: 'I think the behaviour is increasing in frequency'
Post-pub nosh neckfiller: The MIGHTY Scotch egg
Off to the boozer? This delicacy might help mitigate the effects
The next big thing in medical science: POO TRANSPLANTS
Your brother's gonna die, kid, unless we can give him your, well ...
I'M SO SORRY, sobs Rosetta Brit boffin in 'sexist' sexy shirt storm
'He is just being himself' says proud mum of larger-than-life physicist
NASA launches new climate model at SC14
75 days of supercomputing later ...
Britain's HUMAN DNA-strewing Moon mission rakes in £200k
3 days, and Kickstarter moves lander 37% nearer takeoff
prev story

Whitepapers

Why and how to choose the right cloud vendor
The benefits of cloud-based storage in your processes. Eliminate onsite, disk-based backup and archiving in favor of cloud-based data protection.
Getting started with customer-focused identity management
Learn why identity is a fundamental requirement to digital growth, and how without it there is no way to identify and engage customers in a meaningful way.
5 critical considerations for enterprise cloud backup
Key considerations when evaluating cloud backup solutions to ensure adequate protection security and availability of enterprise data.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
Managing SSL certificates with ease
The lack of operational efficiencies and compliance pitfalls associated with poor SSL certificate management, and how the right SSL certificate management tool can help.